Accelerating Clinical Trials (ACT) is a pan-Canadian initiative dedicated to transforming the clinical trial landscape through collaboration, infrastructure development, and strategic innovation. As both an N2 member and national collaborator, ACT plays a vital role in strengthening trial readiness, improving access to research, and supporting system-level solutions that benefit researchers and participants across the country.

Through ACT’s leadership, Canada is working toward a more connected and efficient clinical trials ecosystem—one that is patient-oriented, data-enabled, and nationally aligned. Together, ACT and N2 are committed to shared goals: reducing barriers, promoting high standards, and ensuring that clinical trials in Canada are both responsive and resilient.